![Ronald Cooper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Cooper
Chief Executive Officer at
ENGENE THERAPEUTICS INC.
Net worth: 18 500 $ as of 2026-05-30
Profile
Ronald Harold Wilfred Cooper is President, Chief Executive Officer & Director at enGene Therapeutics, Inc. since 2024.
Mr. Cooper is Chairman at C4 Therapeutics, Inc. since 2024.
Mr. Cooper was President, Chief Executive Officer & Director at Albireo AB. Mr. Cooper was President, Chief Executive Officer & Director at Albireo Pharma, Inc. from 2016 to 2023.
Mr. Cooper was Independent Director at Genocea Biosciences, Inc. from 2016 to 2021.
Mr. Cooper was Director at Albireo Ltd. from 2016 to 2021.
Mr. Cooper was Independent Director at Generation Bio Co. from 2021 to 2026.
Mr. Cooper was President-Europe at Bristol Myers Squibb Co. from 2010 to 2015.
Mr. Cooper completed undergraduate education at St. Francis Xavier University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-23 | 10,000 ( 0.01% ) | 18 500 $ | 2026-05-30 | |
| 2026-04-21 | 0 ( -.--% ) | - $ | 2026-05-30 |
Ronald Cooper active positions
| Companies | Position | Start |
|---|---|---|
| C4 THERAPEUTICS, INC. | Chairman | 2024-06-06 |
| ENGENE THERAPEUTICS INC. | Chief Executive Officer | 2024-07-20 |
Former positions of Ronald Cooper
| Companies | Position | End |
|---|---|---|
| GENERATION BIO CO. | Director/Board Member | 2026-02-05 |
| ALBIREO PHARMA, INC. | Chief Executive Officer | 2023-03-01 |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Chief Executive Officer | 2016-10-31 |
| GENOCEA BIOSCIENCES, INC. | Director/Board Member | 2021-04-11 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2015-10-31 |
Training of Ronald Cooper
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
St. Francis Xavier University
 St. Francis Xavier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
- Stock Market
- Insiders
- Ronald Cooper
